ClinicalTrials.gg
Sign In

Klatskin Tumor clinical trials

The registry lists 82 studies for Klatskin Tumor across more than 10 countries. 27 are recruiting or about to start. 64 of them are mainly about Klatskin Tumor (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Klatskin Tumor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
23
Recruiting
19
Status unknown
19
Not yet recruiting
8
Terminated
6
Active, not recruiting
4

Phase

Phase 2
19
Phase 1
7
Phase 4
4
Phase 3
4

Where

China
29
United States
14
Netherlands
9
Germany
7
Italy
6
France
5

Who runs them

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (4) · Erasmus Medical Center (4) · National Cancer Institute (NCI) (3) · Azienda Ospedaliera di Padova (2) · Khon Kaen University (2) · RedHill Biopharma Limited (2) · Hepatopancreatobiliary Surgery Institute of Gansu Province (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)

What is being tested here

Drugs under test in Klatskin Tumor studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Gemcitabine212
Tislelizumab101
Pembrolizumab111
Cisplatin111
Capecitabine004
Fluorouracil003
Binimetinib001
Rilvegostomig011
Sacituzumab govitecan001
Oxaliplatin001

Drug classes tested here Antimetabolites 2 open · Immune checkpoint inhibitors 2 open

Coming up

2phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 19 Klatskin Tumor studies recruiting now, 11 (58%) set no upper age limit and 5 (26%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (5%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
100 (0%)0 (0%)
1819 (100%)19 (100%)
3019 (100%)19 (100%)
4019 (100%)19 (100%)
5019 (100%)19 (100%)
6519 (100%)19 (100%)
7516 (84%)16 (84%)
8511 (58%)11 (58%)

Across all 82 studies, recruiting or not: 18% stop at 75 or younger and 2% at 65; 7% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 82. Browse all 82 → or search them.